ERK5 activates NF-kappaB in leukemic T cells and is essential for their growth in vivo

Johan Garaude1, Seyma Cherni, Sandra Kaminski

  • 1Institut de Génétique Moléculaire de Montpellier, Centre National de la Recherche Scientifique-Unité Mixte de Recherche 5535, IFR 122, 1919 Route de Mende, 34293 Montpellier, France.

Insights

Reducing ERK5 levels hinders leukemic T cell survival and tumor growth. This highlights ERK5 as a potential therapeutic target for T-cell malignancies, impacting cell viability and apoptosis.

Area of Science:

  • Cellular signaling pathways
  • Molecular biology
  • Cancer research

Background:

  • Mitogen-activated protein kinase (MAPK) cascades are crucial for cellular environmental responses.
  • The MAPK ERK5 pathway regulates proliferation and survival based on cellular context.
  • ERK5 signaling is implicated in growth factor and stress responses.

Purpose of the Study:

  • To investigate the role of ERK5 in leukemic T cell survival and proliferation.
  • To determine if ERK5 is a viable therapeutic target for T-cell malignancies.

Main Methods:

  • Utilized small hairpin RNA targeting ERK5 (shERK5) to reduce ERK5 levels.
  • Assessed cell viability, apoptosis, and NF-kappaB p65 subunit nuclear localization.
  • Evaluated tumor formation in vivo using the EL-4 T lymphoma cell line.

Main Results:

  • Reduced ERK5 levels decreased cell viability and increased sensitivity to apoptosis.
  • shERK5 inhibited nuclear accumulation of NF-kappaB p65 and its transactivation.
  • ERK5 activation promoted constitutive nuclear localization of p65.
  • EL-4 cells with shERK5 proliferated in vitro but failed to form tumors in vivo.

Conclusions:

  • ERK5 is essential for the survival of leukemic T cells in vivo.
  • Targeting ERK5 may offer a promising therapeutic strategy for T-cell malignancies.
  • ERK5 signaling influences NF-kappaB pathway activation, impacting cell fate.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...